Clinical Trial: Efficacy of 5 Weeks of Treatment With BGG492 in Patients With Spasticity Due to Multiple Sclerosis

Study Status: Withdrawn
Recruit Status: Withdrawn
Study Type: Interventional




Official Title: A Multicenter, Randomized, Double-blind, Placebo Controlled, Parallel-group Study to Assess the Efficacy of 5 Weeks of Treatment With BGG492 in Patients With Spasticity Du

Brief Summary: To evaluate efficacy and safety of BGG492 versus placebo on moderate to severe spasticity due to multiple sclerosis